DocuSign Inc DOCU reported Q2 revenue of $511.8 million, beating the analyst consensus of $487.5 million. The EPS of $0.47 beat the consensus of $0.40. It sees Q3 revenue between $526 million - $532 million above the consensus of $520.6 million.
Analyst Reaction: Analysts raised their price targets on subscription and billing growth prospects. Needham analyst Scott Berg raised the PT to $340 from $275, implying a 15.4% upside, and reiterated a Buy on "strong" Q2 with a "typical" upside to revenue and profitability.
Berg notes that DocuSign's sales metrics and growth decelerated sequentially, albeit at a slower rate than the Street consensus. He considers the outlook as conservative.
RBC Capital analyst Rishi Jaluria raised the PT to $345 from $280, signifying a 17.1% upside, and maintained an Outperform. The results reflect the sustainability of the company's tailwinds post-pandemic on solid billings, net revenue retention, and impressive traction with CLM and Notary.
Baird analyst William Power raised the PT to $330 from $320, indicating a 12% upside, and affirmed an Outperform.
UBS analyst Karl Keirstead raised the PT to $350 from $340, implying an 18.8% upside, and reiterated a Buy. The results reflected a "long tail" of sustainable growth, with subscription revenue growth and billings growth beating estimates.
JMP Securities analyst Patrick Walravens raised the PT to $320 from $310, signifying an 8.6% upside, and maintained an Outperform. Walravens considers it a clear leader in electronic signature and the broader system of agreement and sees lots of room for growth as DocuSign targets a $50 billion total addressable market.
Citi analyst Tyler Radke raised the PT to $389 from $386, indicating a 32.1% upside, and affirmed a Buy.
Oppenheimer analyst Brian Schwartz raised the PT to $310 from $260, implying a 5.2% upside, and reiterated an Outperform. The results reflect DocuSign as "mission-critical to keep business operations flowing during disruptions and as employees return to work."
Price Action: DOCU shares traded higher by 6.32% at $313.18 on the last check Friday.
Image by mohamed Hassan from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.